ERS International Congress, Milan 2017

---

IPF: from the bench to the bedside

Thematic Poster
Chairs: M. Keane (Dublin 4, Ireland), D. Israel-Biet (Paris, France), C. Ravaglia (Brisighella, Italy), F. Bonella (Dusseldorf, Germany)

Japanese guideline for the treatment of idiopathic pulmonary fibrosis 2017 S. Homma (Tokyo, Japan)
Serum surfactant protein D predicts the outcome of patients with idiopathic pulmonary fibrosis treated with pirfenidone K. Ikeda (Sapporo, Japan)
The effect of mechanical ventilation to acute exacerbation of IPF and CTD-ILD Y. Ma (Beijing, China)
Effect of nintedanib on multidimensional evaluation in patients with IPF K. Kataoka (Seto, Aichi, Japan)
Bronchoalveolar lavage in idiopathic pulmonary fibrosis S. Aouadi (Ariana, Tunisia)
Our transbronchial lung cryobiopsy experience in 29 patient with ILDs A. Çirak (Izmir, Turkey)
Quality of life of idiopathic pulmonary fibrosis patients E. Barczi (Budapest, Hungary)
Impact of specific organic exposure on the prognosis in Idiopathic Pulmonary Fibrosis L. De Sadeleer (LEUVEN, Belgium)
Safety, feasibility and diagnostic yield of bronchoscopic lung cryobiopsy in diffuse parenchymal lung disease- retrospective review of 100 procedures.> A. O'Mahony (Co. Cork, Ireland)
A real life multicenter national study on the use of nintedanib in moderate to severe IPF patients A. Caminati (Milano, MI, Italy)
Mortality in biopsy verified usual interstitial pneumonia and the relation to computed tomography scores V. Søyseth (Oslo, Norway)
Nintedanib in Idiopathic Pulmonary Fibrosis: a single-centre real-life experience A. Fui (La Spezia, SP, Italy)
Plasma fibronectin as the criterion of idiopathic fibrosing alveolitis severity O. Karasyova (Dnepr, Ukraine)
Expression of mRNA of selected inflammatory markers in BALf cells from patients with sarcoidosis and idiopathic pulmonary fibrosis (IPF) M. Maskey-Warzechowska (Warszawa, Poland)
Can clinical data predict rapid decline of lung function in idiopathic pulmonary fibrosis (IPF) patients? V. Müller (Budapest, Hungary)
Assessment of general physicians’ knowledge in the public and private sectors about interstitial lung disease. S. Kulkarni (Aurangabad (Maharashtra), India)
Diffuse alveolar hemorrhage: how relevant is etiology? A. Terras Alexandre (Bragança, Portugal)
Global characterisation of routine care interstitial lung disease diagnostic practice L. Richeldi (Southampton, United Kingdom)
Real-life experience with pirfenidone in idiopathic pulmonary fibrosis (IPF) in a single centre in Italy. A retrospective study. L. Tavanti (Pisa, Italy)